Ferrante Karen Jean

Ferrante Karen Jean is listed in filings as Director at MacroGenics, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including 15 public disclosures. Recent filings connect the profile to MacroGenics, Inc. (MGNX) and Cogent Biosciences, Inc. (COGT). The current snapshot covers public activity from Jul 2, 2024 to May 20, 2026. Reported amounts are shown as $99.4K to $22.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.